Literature DB >> 869974

Serum myoglobin level as diagnostic test in patients with acute myocardial infarction.

M J Stone, M R Waterman, D Harimoto, G Murray, N Willson, M R Platt, G Blomqvist, J T Willerson.   

Abstract

Serum myoglobin levels were measured in normal subjects and patients by means of a newly developed radioimmunoassay. Myoglobin was identified in all of 135 sera from normal adults and ranged between 6 and 85 ng/ml (mean +/- SE 31 +/- 1.3). Raised myoglobin levels were present in 62 of 64 patients with documented acute myocardial infarction, the mean serum concentration being 528 +/- 76 ng/ml. Serial determinations in 46 patients with acute infarct showed that maximum values usually occurred within 4 hours after admission. In 19 of 42 cases, raised myoglobin levels preceded the rise in creatine kinase (CK) values; in the remaining patients, both serum myoglobin and creatine kinase were increased on admission. Only 2 of an additional 44 patients admitted with chest pain but without subsequent electrocardiographic, enzyme, or technetium-99m stannous pyrophosphate myocardial scintigraphic evidence of acute myocardial infarction had raised myoglobin levels; the mean value for this group was within the normal range (44 +/- 6 ng/ml). Serum myoglobin values also were normal in patients with congestive heart failure without acute myocardial infarction, and in patients after moderate exercise and cardiac catheterisation. Trasient myoglobinaemia appears to be one of the earliest laboratory abnormalities occurring in acute myocardial infarction and, therefore, should prove useful as a diagnostic aid in patients.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 869974      PMCID: PMC483248          DOI: 10.1136/hrt.39.4.375

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  10 in total

1.  Acute myocardial infarction diagnosed by myoglobinuria.

Authors:  H A Kessler; P R Liebson; H Mattenheimer; E C Adams
Journal:  Arch Intern Med       Date:  1975-09

2.  Technetium stannous pyrophosphate myocardial scintigrams in patients with chest pain of varying etiology.

Authors:  J T Willerson; R W Parkey; F J Bonte; S L Meyer; J M Atkins; E M Stokley
Journal:  Circulation       Date:  1975-06       Impact factor: 29.690

3.  Detection and sizing of acute myocardial infarcts with 99mTc (Sn) tetracycline.

Authors:  B L Holman; M Lesch; F G Zweiman; J Temte; B Lown; R Gorlin
Journal:  N Engl J Med       Date:  1974-07-25       Impact factor: 91.245

4.  The importance of identification of the myocardial-specific isoenzyme of creatine phosphokinase (MB form) in the diagnosis of acute myocardial infarction.

Authors:  G S Wagner; C R Roe; L E Limbird; R A Rosati; A G Wallace
Journal:  Circulation       Date:  1973-02       Impact factor: 29.690

5.  Immunologic detection of myoglobinuria after cardiac surgery.

Authors:  L J Kagen
Journal:  Ann Intern Med       Date:  1967-12       Impact factor: 25.391

6.  Factors influencing infarct size following experimental coronary artery occlusions.

Authors:  P R Maroko; J K Kjekshus; B E Sobel; T Watanabe; J W Covell; J Ross; E Braunwald
Journal:  Circulation       Date:  1971-01       Impact factor: 29.690

7.  A new diagnostic test for acute myocardial infarction. The detection of myoglobinuria by radioimmunodiffusion assay.

Authors:  H J Saranchak; S H Bernstein
Journal:  JAMA       Date:  1974-06-03       Impact factor: 56.272

8.  Myoglobinemia following acute myocardial infarction.

Authors:  L Kagen; S Scheidt; L Roberts; A Porter; H Paul
Journal:  Am J Med       Date:  1975-02       Impact factor: 4.965

9.  Radioimmunoassay of myoglobin in human serum. Results in patients with acute myocardial infarction.

Authors:  M J Stone; J T Willerson; C E Gomez-Sanchez; M R Waterman
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

10.  Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity.

Authors:  W E Shell; J K Kjekshus; B E Sobel
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

  10 in total
  31 in total

1.  Marvin Jules Stone, MD, MACP: a conversation with the editor. Interview by William Clifford Roberts.

Authors:  M J Stone
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-10

2.  Increase in cardiac myosin binding protein-C plasma levels is a sensitive and cardiac-specific biomarker of myocardial infarction.

Authors:  Suresh Govindan; Diederik Wd Kuster; Brian Lin; Daniel J Kahn; Walter P Jeske; Jeanine M Walenga; Fred Leya; Debra Hoppensteadt; Jawed Fareed; Sakthivel Sadayappan
Journal:  Am J Cardiovasc Dis       Date:  2013-06-10

Review 3.  Cardiac myofibrillar proteins: biochemical markers to estimate myocardial injury.

Authors:  K H Haider; W H Stimson
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

Review 4.  Non-invasive assessment of the effects of drugs on acute myocardial infarct size in man.

Authors:  D Maclean
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335

5.  Radioimmunoassay of serum myoglobin in screening for acute myocardial infarction.

Authors:  L Reese; P Uksik
Journal:  Can Med Assoc J       Date:  1981-06-15       Impact factor: 8.262

6.  Serum levels of myoglobin and creatine kinase in Duchenne muscular dystrophy.

Authors:  W R Kiessling; R Beckmann
Journal:  Klin Wochenschr       Date:  1981-04-01

7.  [Myoglobin radioimmunoassay: experience of the diagnosis of skeletal muscle disorders (author's transl)].

Authors:  W R Kiessling; K W Pflughaupt
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1981

Review 8.  Effect of exercise on serum enzyme activities in humans.

Authors:  T D Noakes
Journal:  Sports Med       Date:  1987 Jul-Aug       Impact factor: 11.136

9.  Fatty acid-binding proteinuria diagnoses myocardial infarction in the rat.

Authors:  P G Volders; M M Vork; J F Glatz; J F Smits
Journal:  Mol Cell Biochem       Date:  1993 Jun 9-23       Impact factor: 3.396

10.  Serum myoglobin in primary and secondary skeletal muscle disorders.

Authors:  W R Kiessling; K Ricker; K W Pflughaupt; H G Mertens; I Haubitz
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.